|
| Exchange Disseminated Time 09/02/2017 16:01:13 | Tata Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 08, 2017, inter alia, has approved an investment in the Nutritional Solutions business of Rs. 270 crore for setting up of a state-of-the-art, biotechnology unit in Nellore district, Andhra Pradesh for manufacturing of soluble dietary fibres with cutting-edge health benefits. As informed to the Exchanges vide our letter dated January 30, 2017, the Company has signed an MOU on January 27, 2017 with the Government of Andhra Pradesh in this regard.
These products have been developed entirely through in-house R&D efforts at the Company's Innovation Centre in Pune and will serve demanding and critical segments such as Early Life Nutrition (infant nutrition) and medical foods. The Nutritional Solutions business aims to bridge nutritional imbalances gap by targeting optimal human nutrition, through ingredients, formulations and customised products.
Further, also approved an investment of Rs. 295 crore for setting up of a plant to manufacture precipitated highly dispersible silica in the state of Gujarat.
This specialty chemical represents downstream value addition to the Company's soda ash business.
The technology for manufacturing highly dispersible silica has been developed in-house at its Innovation Centre in Pune and seven patents have already been filed. Precipitated silica is a versatile product with applications in many industries including rubber, coatings, pesticides and oral care.
The proposed investments are in line with the Company's strategy on transformation journey by focusing on building businesses with technology enabled differentiation and brands through greater customer centricity. |
|
|